Abstract
We have reported a case series of five patients with jaw-opening oromandibular dystonia secondary to Wilson's disease (WD), in which the patients were treated with botulinum toxin type A (BTX-A). In all cases, dystonia score was partially reduced three weeks after injections. The most common side effect was transient mild dysphagia. This preliminary study showed that jaw-opening oromandibular dystonia in WD may be partially responsive to the use of BTX-A.
Author supplied keywords
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Cite
CITATION STYLE
Teive, H. A. G., Klüppel, L. E., Munhoz, R. P., Becker, N., Müller, P. R., & Werneck, L. C. (2012). Jaw-opening oromandibular dystonia secondary to Wilson’s Disease treated with botulinum toxin type A. Arquivos de Neuro-Psiquiatria, 70(6), 407–409. https://doi.org/10.1590/S0004-282X2012000600005
Readers over time
Readers' Seniority
Readers' Discipline
